Literature DB >> 33628780

Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.

Lixian Chen1, Zhonglu Ren2,3, Yongming Cai2,3.   

Abstract

Increasing evidence has shown that noncoding RNAs play significant roles in the initiation, progression, and metastasis of tumours via participating in competing endogenous RNA (ceRNA) networks. However, the survival-associated ceRNA in lung adenocarcinoma (LUAD) remains poorly understood. In this study, we aimed to investigate the regulatory mechanisms underlying ceRNA in LUAD to identify novel prognostic factors. mRNA, lncRNA, and miRNA sequencing data obtained from the GDC data portal were utilized to identify differentially expressed (DE) RNAs. Survival-related RNAs were recognized using univariate Kaplan-Meier survival analysis. We performed functional enrichment analysis of survival-related mRNAs using the clusterProfiler package of R and STRING. lncRNA-miRNA and miRNA-mRNA interactions were predicted based on miRcode, Starbase, and miRanda. Subsequently, the survival-associated ceRNA network was constructed for LUAD. Multivariate Cox regression analysis was used to identify prognostic factors. Finally, we acquired 15 DE miRNAs, 49 DE lncRNAs, and 843 DE mRNAs associated with significant overall survival. Functional enrichment analysis indicated that survival-related DE mRNAs were enriched in cell cycle. The survival-associated lncRNA-miRNA-mRNA ceRNA network was constructed using five miRNAs, 49 mRNAs, and 21 lncRNAs. Furthermore, seven hub RNAs (LINC01936, miR-20a-5p, miR-31-5p, TNS1, TGFBR2, SMAD7, and NEDD4L) were identified based on the ceRNA network. LINC01936 and miR-31-5p were found to be significant using the multifactorial Cox regression model. In conclusion, we successfully constructed a survival-related lncRNA-miRNA-mRNA ceRNA regulatory network in LUAD and identified seven hub RNAs, which provide novel insights into the regulatory molecular mechanisms associated with survival of LUAD, and identified two independent prognostic predictors for LUAD.
Copyright © 2021 Lixian Chen et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628780      PMCID: PMC7895565          DOI: 10.1155/2021/4093426

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  65 in total

Review 1.  Signal transduction and the Ets family of transcription factors.

Authors:  J S Yordy; R C Muise-Helmericks
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

2.  Decoding competing endogenous RNA networks for cancer biomarker discovery.

Authors:  Xin Qi; Yuxin Lin; Jiajia Chen; Bairong Shen
Journal:  Brief Bioinform       Date:  2020-03-23       Impact factor: 11.622

3.  Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Authors:  Ming-Sound Tsao; Akira Sakurada; Jean-Claude Cutz; Chang-Qi Zhu; Suzanne Kamel-Reid; Jeremy Squire; Ian Lorimer; Tong Zhang; Ni Liu; Manijeh Daneshmand; Paula Marrano; Gilda da Cunha Santos; Alain Lagarde; Frank Richardson; Lesley Seymour; Marlo Whitehead; Keyue Ding; Joseph Pater; Frances A Shepherd
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

Review 4.  Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.

Authors:  Danielle Kamato; Micah L Burch; Terrence J Piva; Hossein Babaahmadi Rezaei; Muhamad Ashraf Rostam; Suowen Xu; Wenhua Zheng; Peter J Little; Narin Osman
Journal:  Cell Signal       Date:  2013-06-11       Impact factor: 4.315

5.  Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition.

Authors:  Molly Brunner; Angélique Millon-Frémillon; Genevieve Chevalier; Inaam A Nakchbandi; Deane Mosher; Marc R Block; Corinne Albigès-Rizo; Daniel Bouvard
Journal:  J Cell Biol       Date:  2011-07-18       Impact factor: 10.539

6.  CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.

Authors:  Run Shi; Chunrong Zhang; Yaqin Wu; Xin Wang; Qi Sun; Jing Sun; Wenjie Xia; Gaochao Dong; Anpeng Wang; Feng Jiang; Lin Xu
Journal:  Oncotarget       Date:  2017-03-21

7.  Dysregulation of Signaling Pathways Due to Differentially Expressed Genes From the B-Cell Transcriptomes of Systemic Lupus Erythematosus Patients - A Bioinformatics Approach.

Authors:  S Udhaya Kumar; D Thirumal Kumar; R Siva; C George Priya Doss; Salma Younes; Nadin Younes; Mariem Sidenna; Hatem Zayed
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

8.  Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.

Authors:  Yiwei Wang; Ting Huang; Xiao Sun; Yudong Wang
Journal:  J Cell Biochem       Date:  2019-07-24       Impact factor: 4.429

9.  Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.

Authors:  Yarui Ma; Siyuan He; Aiai Gao; Ying Zhang; Qing Zhu; Pei Wang; Beibei Yang; Huihui Yin; Yifei Li; Jinge Song; Pinli Yue; Mo Li; Dandan Zhang; Yun Liu; Xiaobing Wang; Mingzhou Guo; Yuchen Jiao
Journal:  Clin Epigenetics       Date:  2020-02-11       Impact factor: 6.551

View more
  3 in total

1.  Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.

Authors:  Juntao Wang; Junde Zhao; Zhiheng Lin; Weisen Fan; Xiaohui Sui
Journal:  Reprod Sci       Date:  2022-07-19       Impact factor: 2.924

2.  Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma.

Authors:  Fang-Wei Li; Sheng-Kang Luo
Journal:  Int J Gen Med       Date:  2021-12-01

3.  Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.

Authors:  Juan Li; Xuyu Gu; Chanchan Gao; Jun Zhang
Journal:  Genet Res (Camb)       Date:  2022-08-27       Impact factor: 1.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.